Literature DB >> 27222152

Role of Flow Cytometry in the Diagnosis of Chronic Granulomatous Disease: the Egyptian Experience.

Rabab El Hawary1, Safa Meshaal2, Caroline Deswarte3,4, Nermeen Galal5, Mahitab Abdelkawy2, Radwa Alkady5, Dalia Abd Elaziz5, Tomas Freiberger6,7, Barbora Ravcukova6, Jiri Litzman7, Jacinta Bustamante3,4,8,9, Jeannette Boutros5, Taghrid Gaafar2, Aisha Elmarsafy5.   

Abstract

INTRODUCTION: Chronic granulomatous disease (CGD) is an inherited mutational defect in any of the NADPH oxidase complex, CYBB (gp91-phox), NCF1 (p47-phox), CYBA (p22-phox), NCF2 (p67-phox), or NCF4 (p40-phox) leading to inability of phagocytes to perform effective respiratory burst and thus diminished killing of bacteria and fungi. The identification of defective proteins aids in establishing a diagnosis prior to genetic analysis, which is rather labor-intensive, expensive, and time-consuming. AIM: The present study aims at assessing the NADPH proteins by performing the intracellular staining with specific monoclonal antibodies and their assessment on flow cytometry. The use of flow cytometry is less laborious and faster to perform than western blot. It also confirms the diagnosis of CGD and detects the affected components allowing proper management of patients.
MATERIALS AND METHODS: Twenty-eight patients from 25 different kindred, clinically suspected as CGD were recruited in Egypt. Dihydrorhodamine test was performed to confirm the diagnosis of the patients. Intracellular staining of NADPH components using specific monoclonal antibodies was performed followed by flow cytometric analysis.
RESULTS: The present study revealed that the most common defective protein in our cohort is p22-phox, found in 13 patients (46.4 % of cases) followed by p47-phox in 8 patients (28.6 %), gp91-phox in 5 patients (17.9 %), and finally p67-phox in 2 patients (7.1 %).
CONCLUSION: In countries with limited resources and yet large number of CGD patients, the analysis of the defective proteins by flow cytometry is an optimum solution for confirming the diagnosis and is a step for targeted sequencing in families seeking prenatal diagnosis.

Entities:  

Keywords:  CYBA; CYBB; Chronic granulomatous disease; Flow cytometry; NCF1; NCF2

Mesh:

Substances:

Year:  2016        PMID: 27222152     DOI: 10.1007/s10875-016-0297-y

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  23 in total

Review 1.  Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (first update).

Authors:  A R Cross; D Noack; J Rae; J T Curnutte; P G Heyworth
Journal:  Blood Cells Mol Dis       Date:  2000-10       Impact factor: 3.039

2.  Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia.

Authors:  R El Kares; M R Barbouche; H Elloumi-Zghal; M Bejaoui; J Chemli; F Mellouli; N Tebib; M S Abdelmoula; S Boukthir; Z Fitouri; S M'Rad; K Bouslama; H Touiri; S Abdelhak; M K Dellagi
Journal:  J Hum Genet       Date:  2006-08-26       Impact factor: 3.172

3.  Limitations on the use of dihydrorhodamine 123 for flow cytometric analysis of the neutrophil respiratory burst.

Authors:  L J van Pelt; R van Zwieten; R S Weening; D Roos; A J Verhoeven; B G Bolscher
Journal:  J Immunol Methods       Date:  1996-05-27       Impact factor: 2.303

Review 4.  Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression.

Authors:  Josef Ben-Ari; Ofir Wolach; Ronit Gavrieli; Baruch Wolach
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

5.  Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease.

Authors:  M Y Köker; K van Leeuwen; M de Boer; F Celmeli; A Metin; T T Ozgür; I Tezcan; O Sanal; D Roos
Journal:  Eur J Clin Invest       Date:  2009-04       Impact factor: 4.686

6.  Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients.

Authors:  Baruch Wolach; Ronit Gavrieli; Martin de Boer; Giora Gottesman; Josef Ben-Ari; Menachem Rottem; Yechiel Schlesinger; Galia Grisaru-Soen; Amos Etzioni; Dirk Roos
Journal:  Clin Immunol       Date:  2008-08-16       Impact factor: 3.969

7.  Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease.

Authors:  Grace Yu; David K Hong; Kira Y Dionis; Julie Rae; Paul G Heyworth; John T Curnutte; David B Lewis
Journal:  Clin Immunol       Date:  2008-08       Impact factor: 3.969

8.  Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease.

Authors:  Shahram Teimourian; Elham Zomorodian; Mohsen Badalzadeh; Alireza Pouya; Caroline Kannengiesser; Davood Mansouri; Taher Cheraghi; Nima Parvaneh
Journal:  Br J Haematol       Date:  2008-04-18       Impact factor: 6.998

9.  Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.

Authors:  Mustafa Yavuz Köker; Yıldız Camcıoğlu; Karin van Leeuwen; Sara Şebnem Kılıç; Işıl Barlan; Mustafa Yılmaz; Ayşe Metin; Martin de Boer; Hüseyin Avcılar; Türkan Patıroğlu; Alişan Yıldıran; Olcay Yeğin; Ilhan Tezcan; Özden Sanal; Dirk Roos
Journal:  J Allergy Clin Immunol       Date:  2013-07-31       Impact factor: 10.793

10.  Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds.

Authors:  Laila Ait Baba; Fatima Ailal; Naima El Hafidi; Marjorie Hubeau; Fabienne Jabot-Hanin; Noufissa Benajiba; Zahra Aadam; Francesca Conti; Caroline Deswarte; Leila Jeddane; Ayoub Aglaguel; Ouafaa El Maataoui; Ahmed Tissent; Chafiq Mahraoui; Jilali Najib; Ruben Martinez-Barricarte; Laurent Abel; Norddine Habti; Rachid Saile; Jean-Laurent Casanova; Jacinta Bustamante; Hanane Salih Alj; Ahmed Aziz Bousfiha
Journal:  J Clin Immunol       Date:  2014-03-05       Impact factor: 8.317

View more
  8 in total

Review 1.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

2.  Clinical and Molecular Features of Chronic Granulomatous Disease in Mainland China and a XL-CGD Female Infant Patient After Prenatal Diagnosis.

Authors:  Shiyu Wang; Tao Wang; Qingqing Xiang; Min Xiao; Yao Cao; Huan Xu; Shujuan Li; Wen Tian; Xiaodong Zhao; Xuemei Tang; Liping Jiang
Journal:  J Clin Immunol       Date:  2019-08-27       Impact factor: 8.317

3.  Flow cytometry optimizing the diagnostic approach in inborn errors of immunity: experience from Egypt.

Authors:  Safa Meshaal; Rabab Ei Hawary; Alia Eldash; Aya Erfan; Dalia Abd Elaziz; Radwa Alkady; Sohilla Lotfy; Nermeen Galal; Jeannette Boutros; Aisha Elmarsafy
Journal:  Allergy Asthma Clin Immunol       Date:  2022-06-02       Impact factor: 3.373

4.  Genetic Counseling in Primary Immunodeficiency Disorders: An Emerging Experience in Egypt.

Authors:  Rabab E El Hawary; Safa S Meshaal; Dalia S Abd Elaziz; Marwa A Elsharkawy; Radwa S Alkady; Sohilla Lotfy; Ahmad El-Sheikhah; Amr Hassan; Nermeen M Galal; Jeannette A Boutros; Aisha M Elmarsafy
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

Review 5.  Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans.

Authors:  Ilaria Marrocco; Fabio Altieri; Ilaria Peluso
Journal:  Oxid Med Cell Longev       Date:  2017-06-18       Impact factor: 6.543

6.  Second Report of Chronic Granulomatous Disease in Jordan: Clinical and Genetic Description of 31 Patients From 21 Different Families, Including Families From Lybia and Iraq.

Authors:  Faris Ghalib Bakri; Michelle Mollin; Sylvain Beaumel; Bénédicte Vigne; Nathalie Roux-Buisson; Adel Mohammed Al-Wahadneh; Raed Mohammed Alzyoud; Wail Ahmad Hayajneh; Ammar Khaled Daoud; Mohammed Elian Abu Shukair; Mansour Fuad Karadshe; Mahmoud Mohammad Sarhan; Jamal Ahmad Wadi Al-Ramahi; Julien Fauré; John Rendu; Marie Jose Stasia
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

7.  Genetic Testing in Egyptian Patients with Inborn Errors of Immunity: a Single-Center Experience.

Authors:  Rabab E El Hawary; Safa S Meshaal; Dalia S Abd Elaziz; Radwa Alkady; Sohilla Lotfy; Alia Eldash; Aya Erfan; Engy A Chohayeb; Mai M Saad; Rania K Darwish; Jeannette A Boutros; Nermeen M Galal; Aisha M Elmarsafy
Journal:  J Clin Immunol       Date:  2022-04-28       Impact factor: 8.542

Review 8.  Recent advances in understanding and treating chronic granulomatous disease.

Authors:  Andrew Gennery
Journal:  F1000Res       Date:  2017-08-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.